Will You Need a Booster Shot of the COVID-19 Vaccine?
When the first COVID-19 vaccines from Pfizer-BioNTech and Moderna were authorized by the U.S. Food and Drug Administration in December 2020, most people breathed a sigh of relief since both shots were shown to be between 94% and 95% effective in protecting from COVID-19 symptoms. But public health experts warned that nobody really knew how long the protection would last, since the longest clinical trials in people only went to a few months. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) and the chief medical advisor to President Joe Biden, suggested that additional booster ...
Source: TIME: Health - April 16, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Patients of women doctors more likely to be vaccinated against the flu
(University of California - Los Angeles Health Sciences) New UCLA research suggests that elderly patients of female physicians are more likely than those of male physicians in the same outpatient practice to be vaccinated against the flu. This trend holds for all racial and ethnic groups studied and could provide insight into improving vaccination rates for influenza, COVID-19 and other illnesses. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 15, 2021 Category: Infectious Diseases Source Type: news

Patients of women doctors more likely to be vaccinated against the flu
New UCLA research suggests that elderly patients of female physicians are more likely than those of male physicians in the same outpatient practice to be vaccinated against the flu.This trend holds for all racial and ethnic groups studied and could provide insight into improving vaccination rates for influenza, COVID-19 and other illnesses,according to the research letter, which is published in the peer-reviewed JAMA Internal Medicine.Prior studies have shown that female physicianstend tospend more time with their patients, said study author Dr. Dan Ly, anassistant professor in the division of general internal medicine and...
Source: UCLA Newsroom: Health Sciences - April 14, 2021 Category: Universities & Medical Training Source Type: news

Coronavirus vaccine technology is paving the way for a whole new approach to flu shots
Messenger RNA influenza vaccines could be more effective than traditional flu shots and protect against numerous strains for years at time, researchers say. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - April 11, 2021 Category: Consumer Health News Authors: Lindsey Bever Source Type: news

QuickStats: Age-Adjusted Percentage of Adults Aged ≥18 Years Who Had an Influenza Vaccination in the Past 12 Months, by Sex and Race/Ethnicity - National Health Interview Survey, United States, 2019
This report describes the age-adjusted percentage of adults who received an influenza vaccination in the U.S. in 2019. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - April 8, 2021 Category: American Health Tags: Adult Health Influenza (Flu) MMWR Morbidity & Mortality Weekly Report Race and Ethnicity Vaccination Source Type: news

UK Covid: Johnson suggests testing for people returning from ‘green list’ countries could be simplified – as it happened
Prime minister says easyJet boss right to ask whether it would bepossible to use lateral flow tests for some returning travellers. This live blog is now closed -please follow the global coronavirus live blog for updatesEngland ’s Covid vaccine programme could slow sharply, Sage warnsNo 10 refuses to rule out Covid passports being needed to enter shopsUK ’s long Covid patients facing postcode lottery for supportWhat are Covid-status certificates and how might they work?5.32pmBSTMAIL: Call this freedom?#TomorrowsPapersTodaypic.twitter.com/NUI1LWWTiYTELEGRAPH: No end in sight as ⁦@BorisJohnson⁩ says normal is ...
Source: Guardian Unlimited Science - April 6, 2021 Category: Science Authors: Andrew Sparrow Tags: Coronavirus Politics UK news Boris Johnson Labour Vaccines and immunisation Infectious diseases NHS Keir Starmer House of Commons Health Science Medical research Byelections Opinion polls Travel & leisure Cannabis Dru Source Type: news

Researchers Are Hatching a Low-Cost Covid-19 Vaccine
A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic. (Source: NYT Health)
Source: NYT Health - April 5, 2021 Category: Consumer Health News Authors: Carl Zimmer Tags: your-feed-science Clinical Trials Coronavirus (2019-nCoV) MERS (Middle East Respiratory Syndrome) Eggs Immune System Influenza Factories and Manufacturing Antibodies Drugs (Pharmaceuticals) Biology and Biochemistry Gates, Bill and Me Source Type: news

Virus Variants Threaten to Draw Out the Pandemic, Scientists Say
Declining infection rates over all masked a rise in more contagious forms of the coronavirus. Vaccines will stop the spread, if Americans postpone celebration just a bit longer. (Source: NYT Health)
Source: NYT Health - April 3, 2021 Category: Consumer Health News Authors: Apoorva Mandavilli and Benjamin Mueller Tags: your-feed-science Disease Rates Immune System Influenza Vaccination and Immunization Coronavirus (2019-nCoV) AstraZeneca PLC Johnson & Moderna Inc Novavax Inc Oxford University Pfizer Inc Brazil Europe Florida Germany Gre Source Type: news

Should We Keep Wearing Masks Even After the Pandemic Ends?
Riding the New York City subway during cold and flu season used to test your stomach. The woman next to you was coughing. The guy behind her was sneezing. Somebody was always fishing for a tissue. That’s a distant memory now. The subway is far emptier, for one thing—and with the riders onboard almost universally wearing masks, the chorus of sniffles and coughs has been silenced. During the pandemic, the need for that policy is clear. But should the masks stay even after COVID-19 is gone? Before vaccines began rolling out to the general public, masks were among the only tools available for containing SARS-CoV-2,...
Source: TIME: Health - April 2, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news

Johnson & Johnson Expands Phase 2a Clinical Trial of COVID-19 Vaccine Candidate to Include Adolescents
New Brunswick, NJ (April 2, 2021) – Johnson & Johnson (the Company) has begun vaccinating adolescent participants in the ongoing Phase 2a clinical trial for its COVID-19 vaccine candidate, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. “The COVID-19 pandemic has had a profound impact on adolescents, not just with the complications of the disease, but with their education, mental health, and wellbeing,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson. “It is vital that we develop vaccines for eve...
Source: Johnson and Johnson - April 2, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Dual influenza and pneumococcal vaccination cost effective
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2021 Category: Drugs & Pharmacology Source Type: news

The covid bio-terrorism trail leads back to CCP collaborators, Anthony Fauci and Peter Daszak
(Natural News) When controversial, gain-of-function virus research was banned in the United States in October of 2014, top scientists in the government and in the private sector had to immediately halt twenty-one projects related to virus manipulation and vaccine development for influenza viruses and coronaviruses like SARS and MERS. Controversial projects at Harvard, Emory and... (Source: NaturalNews.com)
Source: NaturalNews.com - March 31, 2021 Category: Consumer Health News Source Type: news

Covid-19: variants and vaccination, BMJ
Editorial suggests vaccines against SARS-CoV-2 will be needed for many years, and those vaccines will change as variants become too divergent, similar to vaccines against influenza. National and global surveillance, together with well controlled assays to rapidly identify and characterise variants of concern, will allow us to move from current reactive approach to something much more proactive. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 26, 2021 Category: Consumer Health News Source Type: news

Will COVID-19 vaccines need to be adapted regularly?
Influenza vaccines need to be evaluated every year to ensure they remain effective against new influenza viruses. Will the same apply to COVID-19 vaccines? In order to gauge whether and to what extent this may be necessary, a team of researchers from Charité - Universitätsmedizin Berlin compared the evolution of endemic 'common cold' coronaviruses with that of influenza viruses. (Source: World Pharma News)
Source: World Pharma News - March 25, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Will COVID-19 vaccines need to be adapted regularly?
(Charit é - Universit ä tsmedizin Berlin) Influenza vaccines need to be evaluated every year to ensure they remain effective against new influenza viruses. Will the same apply to COVID-19 vaccines? Researchers from Charit é - Universit ä tsmedizin Berlin compared the evolution of endemic 'common cold' coronaviruses with that of influenza viruses. The researchers predict that, while the pandemic is ongoing, vaccines will need to undergo regular updates. A few years into the post-pandemic period, however, vaccines are likely to remain effective for longer. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 25, 2021 Category: Infectious Diseases Source Type: news

Nanoparticle flu vaccine blocks seasonal and pandemic strains
(University of Washington School of Medicine/UW Medicine) Experimental flu shots have now been developed that protect animals from a wide variety of season and pandemic influenza strains. The vaccine candidate is being advanced toward clinical testing. If proven safe and effective, these next-generation influenza vaccines could replace seasonal options by protecting against more strains that current vaccines don't adequately cover. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 24, 2021 Category: Infectious Diseases Source Type: news

Obesity and influenza vaccinations: Lessons learned for COVID-19
Individuals with obesity are at increased risk of morbidity and mortality from both influenza virus infections and COVID-19. Both influenza and SARS-CoV-2, the viral agent of COVID-19, are respiratory viruses, and the immune response to the infection is similar for both viruses. Using both pre-clinical animal models and clinical research studies with influenza vaccination, we have found significant influenza-specific immune dysfunction with obesity. This immune impairment results in adults with obesity being 2X more likely to develop influenza, despite vaccination. Mechanistically, the impairment is likely related to metab...
Source: The Nutrition Society - March 22, 2021 Category: Nutrition Authors: Lulu Yacob Source Type: news

Flu Vaccine Rate Expected to Reach All-Time High for 2020-2021 Season
FRIDAY, March 19, 2021 -- Two-thirds of U.S. adults have received or intend to receive an influenza vaccination this flu season, according to a survey released by the University of Georgia (UGA). Glen Nowak, director of the UGA Center for Health and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 19, 2021 Category: Pharmaceuticals Source Type: news

The Pandemic and the Limits of Science
What have we learned from the year that lasted a century? (Source: NYT Health)
Source: NYT Health - March 16, 2021 Category: Consumer Health News Authors: Alan Burdick Tags: your-feed-science Coronavirus (2019-nCoV) Science and Technology Vaccination and Immunization Epidemics your-feed-health United States Soper, George A Influenza Source Type: news

Guidance on strain changes in authorised COVID-19 vaccines, MHRA
While developers and other stakeholders are working on testing cross-reactivity of sera from vaccinated people with the new strain in relevant assays, it is important that there is a regulatory approach ready to be implemented should virus mutations at any time make vaccines less efficacious due to insufficient cross-reactivity, and an update of already authorised vaccines is needed. This paper lays out scientific and regulatory considerations. It does not cover unauthorised vaccines currently under development. While the considerations in this paper have been written for vaccines, they may also apply, on a case-by-case ba...
Source: Current Awareness Service for Health (CASH) - March 15, 2021 Category: Consumer Health News Source Type: news

Regular booster vaccines are the future in battle with COVID-19 virus, top genome expert says
The novel coronavirus, which has killed 2.65 million people globally since it emerged in China in late 2019, mutates around once every two weeks, slower than influenza or HIV, but enough to require tweaks to vaccines. (Source: The Economic Times)
Source: The Economic Times - March 15, 2021 Category: Consumer Health News Source Type: news

A general influenza vaccine
(University of Konstanz) New vaccination method for lasting protection against all known influenza mutations in preclinical testing phase - potentially effective also against SARS-CoV-2 - joint research project of the University of Konstanz, University of T ü bingen and Technische Universit ä t Dresden. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 12, 2021 Category: International Medicine & Public Health Source Type: news

Africa: Body to Review Reports of Influenza-Like Illness in Individuals Vaccinated Against Covid-19
[WHO] The GACVS COVID-19 Subcommittee met virtually on Thursday, 25 February 2021, to review available information and data on reports of influenza-like illness in health-care workers who had received COVID-19 vaccines [1]. These symptoms have been reported in several countries. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 9, 2021 Category: African Health Source Type: news

ICYMI: WSJ showcases breakthrough science of COVID-19 vaccines and implications for future medicines
Building on deep scientific knowledge gained from decades of experience with viruses such as MERS, SARS, influenza, HIV and Hepatitis C, biopharmaceutical companies have madeunprecedented progress in advancing treatments and vaccines to help fight COVID-19. At this time, three vaccines and several treatments have received emergency use authorizations (EUAs) from the U.S. Food and Drug Administration (FDA) with one treatment receiving FDA approval. Additional candidates under investigation have also shown promise. (Source: The Catalyst)
Source: The Catalyst - March 8, 2021 Category: Pharmaceuticals Tags: Vaccines Coronavirus Source Type: news

South Africa: What South Africa Must Do to Prepare for the Third Wave Double Whammy of Covid-19 and Flu This Winter
[Daily Maverick] Pandemic preparedness for the third wave of Covid-19 must include a strong influenza prevention strategy, including vaccination. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 8, 2021 Category: African Health Source Type: news

Mount Sinai Develops a Safe, Low-Cost COVID-19 Vaccine That Could Help...
A low-cost COVID-19 vaccine candidate that could be produced in the United States and worldwide using existing influenza virus manufacturing infrastructure has been developed by researchers at Icahn...(PRWeb March 08, 2021)Read the full story at https://www.prweb.com/releases/mount_sinai_develops_a_safe_low_cost_covid_19_vaccine_that_could_help_low_and_middle_income_countries/prweb17778276.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 8, 2021 Category: Pharmaceuticals Source Type: news

National Academy of Medicine Launches Initiative on Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response
The National Academy of Medicine (NAM) has established an international committee (IC) in coordination with the U.S. Department of Health and Human Services ’ Office of Global Affairs (OGA) to inform and facilitate efforts to advance global influenza pandemic preparedness. (Source: News from the National Academies)
Source: News from the National Academies - March 5, 2021 Category: Science Source Type: news

Uptake of Seasonal Influenza Vaccine Lower Among Minorities
THURSDAY, March 4, 2021 -- Among Medicare beneficiaries, there are considerable racial and ethnic disparities in seasonal influenza vaccine (SIV) uptake, with lower uptake for Blacks, Asians, and Hispanics versus Whites, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 4, 2021 Category: Pharmaceuticals Source Type: news

Toward a universal influenza vaccine
(Source: ScienceNOW)
Source: ScienceNOW - March 4, 2021 Category: Science Authors: Malo, C. S. Tags: twis Source Type: news

No Flu Season Will Affect Next Year's Vaccine Prep No Flu Season Will Affect Next Year's Vaccine Prep
Low influenza case numbers are'strikingly different'this year and will change the trajectory of next year's flu season and vaccine planning.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - March 3, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Another Covid-19 Threat: Health Care Workers Under Attack
A healthcare worker at a testing facility collects samples for the coronavirus at Mimar Sinan State Hospital, Buyukcekmece district in Istanbul, Turkey. Credit: UNDP Turkey/Levent KuluBy Joe Amon and Christina WillePHILADELPHIA, US, Mar 3 2021 (IPS) In the first months of the COVID-19 pandemic, at a certain hour of the evening, people in cities around the world opened their windows or stood on their rooftops and banged pots and rang bells. As the coronavirus spread and the number of deaths mounted, it was a moment for people distancing themselves from others to show solidarity and appreciation for the heroic work of health...
Source: IPS Inter Press Service - Health - March 3, 2021 Category: International Medicine & Public Health Authors: Joe Amon and Christina Wille Tags: Global Headlines Health TerraViva United Nations Source Type: news

Vaccine development software shows promise in influenza effort, could help defeat coronavirus
A novel computer algorithm that could create a broadly reactive influenza vaccine for swine flu also offers a path toward a pan-influenza vaccine and possibly a pan-coronavirus vaccine as well, according to a new paper published in Nature Communications. (Source: World Pharma News)
Source: World Pharma News - March 3, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

U.S. Will Have Enough COVID-19 Vaccines for All Adults by End of May, Biden Says
(WASHINGTON) — President Joe Biden said Tuesday that the U.S. expects to take delivery of enough coronavirus vaccines for all adult Americans by the end of May, two months earlier than anticipated, as his administration announced that drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved shot. With the bolstered supply, Biden also announced he would be using the powers of the federal government to direct all states to prioritize vaccinating teachers, and said the federal government would provide the doses directly through its pharmacy program. He challenged states to administe...
Source: TIME: Health - March 2, 2021 Category: Consumer Health News Authors: ZEKE MILLER, LINDA A. JOHNSON and JONATHAN LEMIRE/AP Tags: Uncategorized COVID-19 wire Source Type: news

Demographic Impact of Coronavirus Pandemic: An Overview
One year after the pandemic was officially declared, the enormous demographic impact of the coronavirus is becoming increasingly evident as more data are compiled and analyzed. Credit: United Nations.By Joseph ChamieNEW YORK, Mar 2 2021 (IPS) The demographic impact of the coronavirus one year after being declared a pandemic on 11 March 2020 has been enormous. The picture that emerges is one of significant consequences on the levels and trends of the key components of demographic change: mortality, fertility and migration. In terms of mortality, the reported number of Covid-19 deaths worldwide is approaching 3 million, with...
Source: IPS Inter Press Service - Health - March 2, 2021 Category: International Medicine & Public Health Authors: Joseph Chamie Tags: Global Headlines Health Population Source Type: news

Vaccine shows signs of protection against dozen-plus flu strains
(University of Nebraska-Lincoln) A vaccine candidate developed at the University of Nebraska-Lincoln has demonstrated promising signs of protection against more than a dozen swine flu strains -- and more than a leading, commercially available vaccine. Its success in experiments involving swine suggests that its design could also fast-track efforts to develop a vaccine that protects people against many common strains of influenza. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 2, 2021 Category: Infectious Diseases Source Type: news

Vaccine development software shows promise in influenza effort, could help defeat coronavirus
(DOE/Los Alamos National Laboratory) A novel computer algorithm that could create a broadly reactive influenza vaccine for swine flu also offers a path toward a pan-influenza vaccine and possibly a pan-coronavirus vaccine as well, according to a new paper published inNature Communications. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 1, 2021 Category: Infectious Diseases Source Type: news

Johnson & Johnson Announces U.S. CDC Advisory Committee Recommends First Single-Shot COVID-19 Vaccine for Adults 18 and Older in U.S.
NEW BRUNSWICK, N.J., February 28, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has recommended the first single-shot COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, for individuals 18 years of age and older under the Emergency Use Authorization (EUA) issued by the U.S. Food and Drug Administration (FDA). “For more than 130 years, Johnson & Johnson has come to the aid of people during times of crisis, and we believe ...
Source: Johnson and Johnson - February 28, 2021 Category: Pharmaceuticals Source Type: news

Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use
NEW BRUNSWICK, N.J., February 27, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 years of age and older. This decision was based on the totality of scientific evidence, including data from the Phase 3 ENSEMBLE study that demonstrated the vaccine was 85 percent effective in preventing severe disease across all regions studied, and showed protection agai...
Source: Johnson and Johnson - February 28, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Johnson & Johnson Single-Shot COVID-19 Vaccine Candidate Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee
NEW BRUNSWICK, N.J., February 26, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to recommend Emergency Use Authorization (EUA) for the Company’s single-shot COVID-19 vaccine candidate for adults 18 and older, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. The vote was based on a totality of scientific evidence provided by the Company, including efficacy and safety data from the Phase 3 ENSEMBLE trial. “We are e...
Source: Johnson and Johnson - February 26, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

We ’ll Probably Never Eliminate COVID-19 from the U.S. It’s Still Worth Trying
2021 got off to a grim pandemic start in the U.S. A huge surge in COVID-19 cases followed the holiday season, peaking at around 300,000 new cases on Jan. 8, 2020. More than 20,000 Americans lost their lives to the virus in a single week in January alone and over 146,00 in total have died since the start of the year. But six weeks later, the picture looks more promising. New daily cases have fallen sharply, daily deaths have fallen to levels not seen since Thanksgiving, and the pace of vaccine roll-out is speeding up. These positive trends mean that we can now begin to ask what the endgame might look like. Would we be happy...
Source: TIME: Health - February 25, 2021 Category: Consumer Health News Authors: William Hanage and Gavin Yamey Tags: Uncategorized COVID-19 Source Type: news

Pfizer-BioNTech Announces They Will Test a Third Dose of Their COVID-19 Vaccine
Pfizer-BioNTech has begun testing a third dose of its COVID-19 vaccine in a small group of people. The vaccine is currently authorized in several countries in a two-dose regimen, given 21 days apart, and has proven in studies to be about 95% effective in protecting against COVID-19 disease. But as new (and more infectious) genetic variants of the COVID-19 virus start circulating—so far, scientists have identified three major strains, first found in the U.K., South Africa, and Brazil, respectively—questions about how well authorized vaccines can still thwart the virus have become more urgent. Pfizer-BioNTech hav...
Source: TIME: Health - February 25, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Children Given Flu Shot Less Likely to Have Symptomatic COVID-19
WEDNESDAY, Feb. 24, 2021 -- Children who have received an influenza vaccine are less likely to have symptomatic COVID-19 or severe disease, according to a study recently published in Cureus. Anjali Patwardhan, M.D., and Adrienne Ohler, Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 24, 2021 Category: Pharmaceuticals Source Type: news

Flu vaccination this season likely to be highest ever
(University of Georgia) More U.S. adults reported receiving or planning to receive an influenza vaccination during the 2020-2021 flu season than ever before, according to findings from a national survey. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 24, 2021 Category: Infectious Diseases Source Type: news

Do we know how effective vaccines are against the variants? Your COVID-19 questions answered
The good news is the coronavirus that causes COVID-19 doesn't seem to mutate as much or as quickly as the influenza virus that causes the flu. But drugmakers are already re-working their vaccines just in case. (Source: CBC | Health)
Source: CBC | Health - February 23, 2021 Category: Consumer Health News Tags: News/Health Source Type: news

Will we need booster shots against the variants? Your COVID-19 questions answered
The good news is the coronavirus that causes COVID-19 doesn't seem to mutate as much or as quickly as the influenza virus that causes the flu. But drugmakers are already re-working their vaccines just in case. (Source: CBC | Health)
Source: CBC | Health - February 23, 2021 Category: Consumer Health News Tags: News/Health Source Type: news

Afluria Quadrivalent (Influenza Vaccine)
Title: Afluria Quadrivalent (Influenza Vaccine)Category: MedicationsCreated: 2/19/2021 12:00:00 AMLast Editorial Review: 2/19/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - February 19, 2021 Category: Drugs & Pharmacology Source Type: news

It ’s Not Clear That We Actually Need Human Challenge Trials for COVID-19, But the U.K. Is Moving Ahead With Them Anyway
On Feb. 17, health officials in the UK announced that they are ready to start exposing healthy volunteers to the COVID-19 virus in a carefully controlled study. The so-called human challenge trial is the first of its kind for COVID-19 and will help scientists learn how much virus is needed to cause infection, among other important questions. The practice of intentionally exposing healthy people to a disease-causing (and potentially deadly) pathogen isn’t new in science, but it remains controversial. Scientists must balance the benefits of exposing people—which mostly fall in the realm of new knowledge about the...
Source: TIME: Health - February 18, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

< i > The Lancet Healthy Longevity < /i > : Study finds racial and ethnic disparities in flu vaccine uptake among people aged 65 and older in the USA
(The Lancet) A new study published today inThe Lancet Healthy Longevity journal has found significant racial and ethnic disparities in uptake of the seasonal influenza vaccine among people aged 65 years and over in the USA. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 18, 2021 Category: Infectious Diseases Source Type: news

ACIP Releases 2021 Child/Adolescent Vaccine Schedule ACIP Releases 2021 Child/Adolescent Vaccine Schedule
Changes include new recommendations on the influenza and meningococcal vaccines and guidance on COVID-19 vaccines.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 11, 2021 Category: Consumer Health News Tags: Pediatrics News Alert Source Type: news